Martin Dow assigned A+ rating

KARACHI: The Pakistan Credit Rating Agency (PACRA) has assigned the long-term rating of A+ and the short-term rating of A1 with a stable outlook to Martin Dow Marker Limited Pakistan, a statement said on Thursday.

Martin Dow Marker Limited is a notable name in the pharmaceutical segment of Pakistan operating since 1951. The company operates under the umbrella of Martin Dow Group, one of the largest locally-owned pharmaceutical Groups, it added.

Expressing his views after the announcement, Javed Ghulam Mohammad, group managing director and CEO of Martin Dow said, “With an uninterrupted legacy of over half a century, Martin Dow Group is benchmarked to deliver quality products that continue to contribute to the health of millions of people across the globe.”

“We are proud to have received the long-term credit rating of A+ and the short-term rating of A1 by PACRA, reflecting positively on the high standards of our operations.”

The company has a diversified portfolio with a large manufacturing footprint in Pakistan. It markets research-based products through strategic alliances with global pharmaceutical groups and selling world-class branded generics, which are developed, formulated, and manufactured at its state-of-the-art cGMP compliant manufacturing facilities located in Quetta and Karachi, it added.